These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7092184)

  • 1. Biochemical findings in a case of parkinsonism secondary to brain tumor.
    García de Y'ebenes J; Gervas JJ; Iglesias J; Mena MA; Martín del Rio R; Somoza E
    Ann Neurol; 1982 Mar; 11(3):313-6. PubMed ID: 7092184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
    Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
    Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA; Rothblat DS; Joyce JN; Schneider JS
    Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
    Mjörndal T; Winblad B
    Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
    Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
    Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
    Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
    Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
    Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats.
    Kuter K; Smiałowska M; Wierońska J; Zieba B; Wardas J; Pietraszek M; Nowak P; Biedka I; Roczniak W; Konieczny J; Wolfarth S; Ossowska K
    Brain Res; 2007 Jun; 1155():196-207. PubMed ID: 17493592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological features in hydrocarbon-induced parkinsonism.
    Pezzoli G; Strada O; Silani V; Zecchinelli A; Perbellini L; Javoy-Agid F; Ghidoni P; Motti ED; Masini T; Scarlato G; Agid Y; Hirsch EC
    Ann Neurol; 1996 Dec; 40(6):922-5. PubMed ID: 9007099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
    Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
    Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An autopsy case of chorea-acanthocytosis. Special reference to the histopathological and biochemical findings of basal ganglia].
    Sato Y; Ohnishi A; Tateishi J; Onizuka Y; Ishimoto S; Iwashita H; Kuroiwa Y; Kanazawa I
    No To Shinkei; 1984 Feb; 36(2):105-11. PubMed ID: 6203544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
    Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.